60+ Patient Organizations Join NORD in Letter to Congress
WASHINGTON DC, July 25, 2013—–More than 60 rare disease patient organizations signed a letter delivered to key members of Congress today by the National Organization for Rare Disorders (NORD) in support of maintaining the Orphan Drug Tax Credit. The letter quotes NORD medical adviser and former Director of FDA’s Office of Orphan Products Development Marlene [&hellip
